AMAbolfazl Movafagh

Abolfazl Movafagh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abolfazl Movafagh has a total of 183 co-authors. Here are the top co-authors by number of shared publications:

  • Neda Mansouri

    Instituto de Biología Molecular y Celular del Cáncer (CSIC-Universidad de Salamanca). IBSAL and CIBERONC, Salamanca, Spain

    5 shared publications
  • Mehrdad Hashemi

    Department of Genetics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

    4 shared publications
  • Narjes Mehrvar

    MAHAK Hematology Oncology Research Center (MAHAK-HORC), MAHAK Hospital

    4 shared publications
  • Afshin Moradi

    Cancer Research Center, Department of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Azim Mehrvar

    MAHAK Hematology Oncology Research Center (MAHAK-HORC), MAHAK Hospital

    3 shared publications
  • Hossein Darvish

    Neuroscience Research Center, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

    3 shared publications

Latest Publications

  • Open Access

    The Significant Role of RUNX2 Expression in Women with Metastatic Breast Cancer

    by Mitra Rezaei, Neda Mansouri, Zihab Sohbatzadeh, Rezvaneh Ghadyani, Shahrzad Soleimani, Marzieh Motallebi, Ehsan Parsa Zad, Maryam Torkaman, Ali Asghar Kolahi, Abolfazl Movafagh

    Objective: Breast cancer (BC) is one of the most common malignancies with second ranks among the causes of tumor-associated mortality in females. Since the overexpression of RUNX2 gene were reported in the development of different malignancies. The present investigation was aimed to find its correlation with prognostic factors viz, tumor grade and stage in the breast cancer patients. Methods: This study, examined the expression level changes of RUNX2 genes with the Real-time PCR and compared the results with various databases and previous research results, to understand the existence of differences between metastatic breast cancer patients’ samples and non-metastatic BC samples of patients. Results: The prepared samples were divided into two target and control groups and different analyses after QPCR reaction were accomplished to understand the level of changes and significance. Conclusion: Results of this study suggest that an elevated RUNX2 gene expression level could be a valuable independent predictor of tumor metastasis and survival prediction in invasive breast cancer patients. However, to reach more reliable results and better conclusions more samples, studies, and techniques are needed.

  • Open Access

    Nano delivery of MiR-146a and its Effect Study on Genes Involved in Apoptosis and Autophagy Pathways in Lung Cancer and Tuberculosis

    by Mojgan Sheikhpour, Mobina Maleki, Hanie Sakhi, Abolfazl Movafagh, Seyed Ali Nojoumi, Leila Ghazizadeh

    Background Tuberculosis (TB) and lung cancer (LC) are among the leading causes of death worldwide and present serious challenges in diagnosis and treatment. Therefore, developing new strategies for their treatment is crucial. MicroRNAs (miRNAs) are biological molecules that play a critical role in regulating essential processes, such as apoptosis and autophagy, in TB and LC by targeting specific genes. Recently, the use of carbon nanotubes functionalized with Polyethyleneimine (CNT-PEI) to deliver miRNAs to target cells has been investigated to enhance therapeutic effects. Methods In this study, miR-146a was transfected into LC (A549), macrophages infected with TB (THP1), and healthy lung cells (MRC5) using CNT-PEI. Then, the expression of miR-146a and its target genes, including BCL-2, IL-6, tumor necrosis factor-alpha (TNFα), and TNF receptor-associated factor-6 (TRAF6), were measured using Real-Time PCR. Finally, the effect of overexpression of miR-146a on these genes was investigated in all three cell lines. Result The results showed successful transfection of miR-146a using the CNT-PEI nano delivery system in LC and TB cells. Then, increased expression of miR-146 increased apoptosis and autophagy by targeting the TRAF6 gene and affecting other genes such as BCL-2, IL-6, and TNFα through the NF-kB signaling pathway. Conclusion The findings suggest an important role for miR-146a in TB and LC, which regulates inflammatory responses and treats these diseases. However, further studies are needed on the use of CNT-PEI in vivo, as well as the balance between local anti-inflammatory and non-inflammatory factors.

  • The T Cell Receptor Repertoire Diversity Following Hematopoietic Stem Cell Transplantation

    by Fahimeh Zamani, Reza Mirfakhraie, Sayyed Reza Safaee Nodehi, Yaghoub Mollaei-Kandelous, Hossein Jafari, Mohammad Farahmand, Farhad Rezaei, Majid Teymoori-Rad, Abolfazl Movafagh

    Immune reconstitution after hematopoietic stem cell transplantation (HSCT) with a conditioning regimen has appeared to be a promising treatment for autoimmune diseases and hematologic malignancies. This study aimed to assess the T cell receptor (TCR) repertoire diversity in CD4+ cells of patients with hematological malignancies who received allogeneic or autologous HSCT. The diversity of the TCR repertoire was evaluated in 13 patients with hematologic malignancies before and four months after HSCT. Amino acid changes in the 25 Vβ families were evaluated using Spectratyping and data were presented as Hamming distance (HD). HD more than 20% was considered a change in TCR repertoire after HSCT. The mean HD was significantly changed after transplantation in all Vβ gene families, with most amino acid changes in p4 and p22 families. There was a strong negative correlation between the HD as the index of TCR repertoire and age (r=−0.62,). The results revealed no association between HD mean and parameters such as sex, disease, conditioning regimen, and type of transplantation. Our data revealed that commonly used conditioning regimens in Iran could successfully cause TCR repertoire diversity in patients with hematologic malignancies in the short term. The amount of change in TCR repertoire was inversely correlated with the increasing age of patients.

  • Open Access

    Evaluation of the current microRNAs expression levels as potential biomarkers in Oral Squamous Cell Carcinoma

    by Elahe Tahmasebi, Ali Kaboudanian Ardestani, Negar Madihi, Zahra Abbasiparashkouh, Sanam Abbasi Maleki, Mohsen Yazdanian, Mostafa Khafaei, Abolfazl Movafagh, Mahmood Tavallaie

    As the most common malignancy, oral squamous cell carcinoma (OSCC) is typically fatal. The survival of patients with oral cancer has not improved, and tumor recurrence remains high. During tumorigenesis, microRNAs (miRNAs) regulate gene expression. Patients life expectancy can be determined by prognostic survival biomarkers, which can focus therapy on specific targets. This study evaluated five miRNAs associated with OSCC for their prognostic impact. It was determined through microarray analysis and quantitative reverse transcription polymerase chain reaction that there was a significant difference in the expression of miRNAs between OSCC patients and control patients in plasma. We used the unpaired t-tests and the Mann-Whitney test to conduct the statistical analysis. Based on the studys results, five miRNAs have been found to have significantly different expression levels in the plasma of patients with OSCC; in particular, miR-31 was found to have a significantly higher expression level in OSCC patients plasma as compared with healthy controls. Aside from that, there was a significant reduction in the expression of miR-100, miR-199a, miR-203, and mir345 in the plasma of OSCC patients (P


  • Open Access

    Clinical and molecular spectrum of P/Q type calcium channel Cav2.1 in epileptic patients

    by Elham Alehabib, Zahra Esmaeilizadeh, Sakineh Ranji-Burachaloo, Abbas Tafakhori, Hossein Darvish, Abolfazl Movafagh

    Background: Epilepsy is a neurological disorder characterized by the potential to induce seizure and accompanied by cognitive, psychological, and social consequences.CACNA1Agene is a voltage-gated P/Q-type Cav2.1 channel that is broadly expressed in the central nervous system, and the pathogenic variants within this gene may be associated with the epileptic phenotype. In the present study, we collected clinical and molecular data related to epileptic patients withCACNA1Apathogenic variants and investigated possible meaningful relationship between age at onset, neurodevelopmental disorders, type of seizures, brain imaging abnormalities, genotype, and protein domains.Results: In our retrospective literature studies, from among 890 articles reviewed, a total of 90 individuals were related to epilepsy phenotype. Our findings showed that about 90 percent of patients have shown the first symptoms in childhood and teenage years and different types of neurodevelopmental disorders, such as intellectual disability, developmental arrest, and behavioral disorders, have been common findings for these patients. Further, a wide range of abnormalities have been observed in their brain imaging, and generalized seizures have been the most type of seizures in these patients. However, our data showed no specific genotype–phenotype correlation in epileptic patients withCACNA1Apathogenic alterations.Conclusions: Our study focused on epileptic phenotype in patients withCACNA1Apathogenic variants and showed a wide range of clinical and molecular heterogeneity with no specific genotype–phenotype correlation. It seems that incomplete penetrance,de-novovariants, and modifier genes are obstacles in predicting the clinical outcome.


  • Gene mutation of childhood B-acute lymphoblastic leukemia: A systematic review

    by Abolfazl Movafagh, Parisa Naji, Mojgan Sheikhpour

    Introduction: Research on the importance of cancer mainly been performed in acute lymphoblastic leukemia (ALL) B-cell populations. All B-cell is the most common leukemia occurs in 2–5-years old of children. Chromosome translocations, chromosome numerical alterations, and specific gene mutations are the genetic abnormalities which have found in 75% of B-ALL cases. Somatic mutations in 45 genes with different frequency and different cellular pathways were the subject of this investigation. Materials and Methods: An electronic search of peer-reviewed articles was systematically performed to obtain the relevant literature with the Cumulative Index to Nursing and Allied Health Literature, PsycINFO, and PubMed databases. In this systematic review, 48 articles from 1998 to 2020 were collected. The keywords included B-cell ALL, genes, mutations, pediatric, and systematic review. The inclusion criteria for the reviews were that the documents were original quantitative research and published in English. Articles that were not directly relevant to the present objective were excluded. Results: The results are limited to these specific them as B-cell, ALL, pediatric, genes, mutations, and systematic review. This article focused on the pediatric B-cell ALL, support of cancer patients from diverse and heterogeneous groups globally. By collecting the articles and reviewing them, alterations in different genes with different molecular pathways which had the effects on B-ALL pathogenicity were found and alteration list discussed. Conclusion: The present outcome of these review resources suggest that it may be helpful for clinicians to address genetics, epigenetic regulators, particularly with regard to prevention, healing, and survival of pediatric cancer patients. This article indicates that it may be useful for clinical oncologists to be informed of the prevalence of the use of mutated genes in medicine in their specialized field. In addition, patients should routinely be asked about the use of prevention medicine as the part of every cancer patient's evaluation.

  • Open Access

    Comparison and frequency of cell cultured in 48-h and 72-h mitotically treated with phytohemagglutinin-M: Both promise for normal and cancer cells

    by Abolfazl Movafagh, Alireza Abadi, Zeinab Mazloumi, Ali Asghar Kolahi, Mojgan Sheikhpour, Mostafa Rezaei-Tavirani, Afshin Moradi, Mahsa Ahadi, Fatemeh Shaabanpour Aghamaleki, Niloufar Safavi, et al.

    The aim of the present study is hence to comprise of mitotic index outcome in the individuals of normal volunteers involved in two different period of culture with effect of Phytohemagglutinin-M. Comparison of healthy human donors lymphocytes were cultured for 48-h and 72-h and using conventional karyotype technique with minor modification. Mitotic index and cell proliferation frequency were analyzed in the individuals of normal blood donors after preparing of colchicine to cultured metaphases 2 h before cell fixation. The metaphase indices at 48-h and 72-h culture period resulted a perfect yield product. Lymphocytes populations in 72-h laboratory work were more than 48-h cultures (2.73% at 72 h vs. 1.48% at 48 h, P ≤ 0.05). The present research indicates significant comparisons for laboratories and individuals to be set up. With effect of these results, it may help in time-consuming and short time period for patient, as well as fresh suggestion for health-care management decision. Reagent, manual, budget, time for diagnosis, and health-care fulfillment may resolve of this proposal.

  • Characterizing Iranian Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Through Gene Expression Profiling of Common ATP Binding Cassette Transporters Subfamily C

    by Narjes Mehrvar, Hassan Abolghasemi, Mohammad R. Rezvany, Mohammad E. Akbari, Javad Saberynejad, Azim Mehrvar, Abolfazl Movafagh

    Background: The correlation between gene expression of ABCC transporters and recurrence as a treatment failure in pediatric patients with acute lymphoblastic leukemia (ALL) is an unsolved problem in scientific associations. The aim of this study was to evaluate the predictive value of ABCC1-6 gene expression pattern for estimating recurrence in Iranian pediatric patients with ALL. Materials and Methods: Iranian pediatric patients with approved ALL enrolled in this study as 2 groups of case (relapsed ALL) and control (treated individuals who lasted for >3 years following their final treatment). Real-time polymerase chain reaction was done with GAPDH for expressing ABCC1-6 transporter genes. Cumulative doses of Vincristine, Daunorubicin, and L-Asparginase were checked for each patient. Gathered data analyzed with SPSS version 22 and REST 2009 software. Results: Thirty-nine samples as 23 relapsed ALL and 16 controls enrolled. High expression of ABCC2-6 and low expression of ABCC1 were detected in pediatric patients with relapse. ABCC3 and ABCC4 had significant relation with high-risk patients of NCI group. Also, ABCC4 and ABCC6 had more expression with high doses of Daunorubicin and L-Asparginase. Conclusions: Designed expression pattern have the predictive value for estimating of conferring relapse in Iranian pediatric patients with diagnosed ALL. The authors suggest of designing a multiple childhood malignancy center project to evaluate this pattern in a cohort study.


    • 1 July 2019
      • Vol. 8  (2) , 184-193

    Pattern of ABCC Transporter Gene Expression in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia

    by Narjes Mehrvar, Hassan Abolghasemi, Mohammad Reza Rezvany, Mohammad Esmaeil Akbari, Javad Saberynejad, Azim Mehrvar, Mohammad Ali Ehsani, Mahyar Nourian, Ibrahim Qaddoumi, Abolfazl Movafagh

    Background: Abnormal expression of ABCC transporter genes has been associated with treatment failure in pediatric patients with acute lymphoblastic leukemia (ALL). The aim of this study was to evaluate the expression pattern of ABCC1-6 and ABCC10 genes in Iranian pediatric patients with ALL relapse and determine the potential predictive value of determining ALL relapse from ABCC expression. Methods: Patients with ALL were divided into two separate groups, either the case group with relapsed ALL or the control group in which ALL patients have been in progression-free survival for at least 3 years A total of thirty-nine participants (23 with relapsed ALL; 16 controls) were enrolled over 26 months. To determine the levels of ABCC1-6 and ABCC10 transporter gene expression RT-PCR was used. Cumulative doses of the chemotherapy drugs, VCR, DNR and L-ASP, were calculated for each patient. Results: Our findings showed elevated expression of ABCC2-6 and decreased expression of ABCC1 and ABCC10 to be associated with an increased risk of ALL relapse. The mean-fold expression of ABCC2 was significantly increased in the ALL relapse group. Additionally, the expression pattern of the ABCC transporter genes was associated with high doses of three chemotherapy drugs, VCR, DNR and L-ASP. Conclusions: Evaluating the expression pattern of ABCC transporter genes may be a potential biomarker for predicting the occurrence of ALL relapse in Iranian pediatric patients and improve cancer prognosis.


  • ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine

    by Narjes Mehrvar, Mohammad Esmail Akbari, Mohammad Reza Rezvany, Hasan Abolghasemi, Javad Saberynejad, Azim Mehrvar, Mohammad Faranoush, Ali Asghar Keramatinia, Reza Shekarriz-Foumani, Abolfazl Movafagh

    Multidrug resistance based on ABC transporters' gene expression is one of the most important health challenges through chemotherapy of patients. This resistance can cause relapse or treatment failure. The goal of this conducted study was to evaluate the results of published reports which considered ABC transporters' gene expression in pediatric patients with acute leukemia. PubMed as a free search engine was chosen. The following Mesh terms were used as: "ATP-binding cassette transporters” OR "ABC-transporters*” AND "gene expression*” AND "leukemia” OR "ALL” OR "AML” OR "acute leukemia*”. Age was set as an additional filter with the age range of birth to 18 years old. Initial screening was performed according to inclusion and exclusion criteria and the quality of the selected papers was assessed. Papers categorized into three sections as: pediatric patients with ALL (6 papers from 1998-2015); pediatric patients with AML (3 papers from 1992-2011) and pediatric patients with ALL and AML (7 papers from 1992-2014). Totally 1118 patients enrolled in the searched studies (ALL and AML: 488; ALL: 405; AML: 225). The common method for evaluating gene expression of ABC transporters was RT-PCR. More than 50% of the papers showed the influence of ABC transporters' gene expression on prognosis and treatment failures of patients. Despite controversial results, the gathered information in the current report serves as a comprehensive referential resource, which can be beneficial for future planning around this title, especially in developing countries.